Hemodialysis Principles and Dose

Hemodialysis removes solutes and excess fluid by passing blood across a semipermeable artificial membrane against a counter-current dialysate. Its core principles are diffusion of small solutes down concentration gradients and ultrafiltration of water under a pressure gradient. The amount of clearance delivered — the dialysis dose — is a central determinant of how the treatment is prescribed and evaluated.

Definition

Hemodialysis is an extracorporeal renal replacement technique in which blood is circulated across an artificial semipermeable membrane (the dialyzer) so that small solutes diffuse into a counter-flowing dialysate and excess water is removed by ultrafiltration.

Scope

This topic covers the physical principles of hemodialysis (diffusion, convection, ultrafiltration, the dialyzer and dialysate), the concept of dialysis dose and its quantification through measures such as Kt/V, and the major trials that examined whether more dialysis improves outcomes. It is a methodological and conceptual reference, not a prescription for any patient.

Core questions

• How do diffusion, convection, and ultrafiltration each contribute to clearance?
• What is dialysis dose, and how is it quantified?
• Does increasing small-solute dialysis dose improve survival?
• What roles do membrane flux and treatment time play?

Key concepts

• Diffusion across a semipermeable membrane
• Ultrafiltration and convective clearance
• Counter-current dialysate flow
• Dialyzer (artificial kidney)
• Dialysis dose and Kt/V
• Urea reduction ratio
• High-flux versus low-flux membranes

Key theories

Kt/V model of dialysis adequacy

Gotch and Sargent's reanalysis of the National Cooperative Dialysis Study introduced Kt/V — clearance multiplied by time, normalised to urea distribution volume — as a quantitative index of delivered small-solute dialysis dose, establishing the framework still used to express dialysis adequacy.

Mechanisms

Blood is pumped from the patient through the dialyzer, where it is separated from dialysate by a semipermeable membrane. Small solutes such as urea and potassium diffuse from blood into dialysate down their concentration gradients, while the counter-current arrangement of blood and dialysate flow maintains the gradient along the membrane. Applying a transmembrane pressure removes plasma water by ultrafiltration, which also drags solute with it (convective clearance). The delivered small-solute dose is summarised by Kt/V, derived from urea kinetics (Gotch & Sargent, 1985). The HEMO trial tested whether a higher small-solute dose or higher membrane flux improved survival in maintenance hemodialysis and did not find a benefit from the higher targets studied (Eknoyan et al., 2002).

Clinical relevance

Understanding hemodialysis principles supports interpreting how adequacy is measured and how dialysis trials are designed and read. The evidence base informs guideline targets for delivered dose. This entry explains concepts and trial findings descriptively and is not a basis for prescribing dialysis parameters for an individual.

Epidemiology

Hemodialysis is the most common form of long-term renal replacement therapy in many countries. People on maintenance hemodialysis carry a high cardiovascular disease burden, which is the leading cause of death in this population (Foley et al., 1998).

Evidence & guidelines

The National Cooperative Dialysis Study and its kinetic reanalysis defined the dose concept (Gotch & Sargent, 1985), and the HEMO randomised trial subsequently tested higher dose and flux targets (Eknoyan et al., 2002). Adequacy targets are codified in clinical guidelines from kidney bodies, summarised but not reproduced here.

History

Willem Kolff built the first practical artificial kidney in the 1940s. The advent of repeated vascular access — the arteriovenous fistula described by Brescia and Cimino in 1966 — made long-term maintenance hemodialysis feasible (Brescia et al., 1966). The dose concept was formalised through the National Cooperative Dialysis Study in the early 1980s and refined by the kinetic Kt/V analysis (Gotch & Sargent, 1985), with the HEMO trial later probing whether more dialysis helped (Eknoyan et al., 2002).

Debates

Does a higher small-solute dialysis dose improve outcomes?

After the dose concept was established, the HEMO trial tested whether raising the delivered Kt/V or using high-flux membranes reduced mortality and did not demonstrate a benefit from the higher targets studied, focusing attention on factors beyond small-solute clearance.

Key figures

• Willem Kolff
• Belding Scribner
• Frank Gotch
• John Sargent
• Garabed Eknoyan

Seminal works

• gotch-sargent-1985
• eknoyan-2002-hemo
• brescia-cimino-1966

Frequently asked questions

What is the difference between diffusion and ultrafiltration in hemodialysis?

Diffusion moves solutes across the membrane down their concentration gradients into the dialysate and clears small molecules such as urea; ultrafiltration removes water by a pressure gradient and, by solvent drag, also clears some solute convectively.

What does Kt/V measure?

Kt/V is a dimensionless index of delivered small-solute dialysis dose — clearance (K) times treatment time (t) normalised to the urea distribution volume (V) — used to express dialysis adequacy.